McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, Jang GHo, Walch H, Aveson VG, Falvo DJ et al..  2024.  Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.. Cancer Cell. 42(9):1614-1629.e5.

Dusaj N, Papoutsi E, Hoffman KL, Siempos II, Schenck EJames.  2024.  Lost in a number: concealed heterogeneity within the sequential organ failure assessment (SOFA) score.. Crit Care. 28(1):6.

Wankowicz SAM, Werner L, Orsola A, Novak J, Bowden M, Choueiri TK, de Torres I, Morote J, Freeman GJ, Signoretti S et al..  2017.  Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.. J Urol. 198(4):817-823.

Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y et al..  2017.  Recurrent genetic defects on chromosome 5q in myeloid neoplasms.. Oncotarget. 8(4):6483-6495.

Sendoel A, Dunn JG, Rodriguez EH, Naik S, Gomez NC, Hurwitz B, Levorse J, Dill BD, Schramek D, Molina H et al..  2017.  Translation from unconventional 5' start sites drives tumour initiation.. Nature. 541(7638):494-499.

Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V.  2016.  An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.. Int J Gynecol Cancer. 26(3):497-504.

Wang D, Narula N, Azzopardi S, Smith RS, Nasar A, Altorki NK, Mittal V, Somwar R, Stiles BM, Du Y-CNancy.  2016.  Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.. Oncotarget. 7(26):39957-39969.

Gaeta SA, Ward C, Krasuski RA.  2016.  Extra-cardiac manifestations of adult congenital heart disease.. Trends Cardiovasc Med. 26(7):627-36.

Becker A, Thakur BKumar, Weiss JMitchell, Kim HSang, Peinado H, Lyden D.  2016.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.. Cancer Cell. 30(6):836-848.

Azzopardi S, Pang S, Klimstra DS, Du Y-CNancy.  2016.  p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.. Neoplasia. 18(10):610-617.

Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A et al..  2016.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.. Genome Biol. 17(1):231.

Thomas AA, Fisher JL, Rahme GJ, Hampton TH, Baron U, Olek S, Schwachula T, C Rhodes H, Gui J, Tafe LJ et al..  2015.  Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.. Neuro Oncol. 17(6):801-9.

Darken RS, Bogitch R, Leonard J, Perry A, McKinstry RC, Gutmann DH, Rubin JB.  2009.  Brainstem glioma presenting as pruritus in children with neurofibromatosis-1.. J Pediatr Hematol Oncol. 31(12):972-6.

Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J et al..  2007.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.. Cancer Cell. 11(2):147-60.

Brewer GJ, Askari FK.  2005.  Wilson's disease: clinical management and therapy.. J Hepatol. 42 Suppl(1):S13-21.